<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-21T12:00:34Z</responseDate><request verb="GetRecord" identifier="oai:repository.ajou.ac.kr:201003/7637" metadataPrefix="oai_dc">https://repository.ajou.ac.kr/oai/request</request><GetRecord><record><header><identifier>oai:repository.ajou.ac.kr:201003/7637</identifier><datestamp>2024-10-11T02:17:40Z</datestamp><setSpec>com_201003_14369</setSpec><setSpec>com_201003_14368</setSpec><setSpec>col_201003_14371</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Modulation of Alzheimer’s Disease Pathology by Collagen-Induced Rheumatoid Arthritis in APP/PS1 Mice</dc:title>
<dc:title>콜라겐 유도에 의한 관절염이 치매동물의 병리기전에 미치는 영향에 관한 연구</dc:title>
<dc:creator>박, 선미</dc:creator>
<dc:contributor>조, 은혜</dc:contributor>
<dc:contributor>곽, 병주</dc:contributor>
<dc:contributor>대학원 의학과</dc:contributor>
<dc:contributor>200624087</dc:contributor>
<dc:contributor>박, 선미</dc:contributor>
<dc:subject>Alzheimer’s disease (AD)</dc:subject>
<dc:subject>Rheumatoid arthritis (RA)</dc:subject>
<dc:subject>Inflammation</dc:subject>
<dc:subject>Blood-brain barrier (BBB)</dc:subject>
<dc:subject>Amyloid beta (Aβ)</dc:subject>
<dc:description>Several evidences suggest that rheumatoid arthritis (RA) may enhance or reduce the progression of Alzheimer’s disease (AD). The present study was performed to directly explore the effects of collagen-induced rheumatoid arthritis (CIA) on cognitive function, amyloid plaque formation, microglial activation, and cerebrovascular pathology in the cortex and hippocampus of the double transgenic APP/PS1 mouse model for AD. Wild-type or APP/PS1 mice that received type II collagen (CII) in complete Freund’s adjuvant (CFA) at presymptomatic stage (2 months) or postsymptomatic stage (8.5 months) of age revealed characteristics of RA, such as joint swelling, synovitis, and cartilage and bone degradation 4 months later. Joint pathology was accompanied by sustained induction of IL-1β and TNF-α in plasma over 4 weeks after administration of CII in CFA. 

In the presymptomatic stage, prior to the onset of plaque formation, CIA reduced levels of soluble and insoluble amyloid beta (Aβ peptides) and amyloid plaque formation in the cortex and hippocampus of APP/PS1 mice, which correlated with increased blood brain barrier disruption, Iba-1 or Mac-1 positive microglia, and CD45-positive microglia/macrophages. In contrast, CIA reduced survival and vessel density and length with features of cerebrovascular pathology including vascular segments, thinner vessels, and atrophic string vessels. 

In the postsymptomatic stage, after the onset of amyloid plaque formation, CIA mice improved cognitive function behavior based on the performance in the MWM and the Y-Maze and reduced amyloid plaque pathology. Additionally CIA mice increased cerebrovascular pathology and mortality. 

The present findings suggest that RA may exert beneficial effects against Aβ burden and harmful effects on cerebrovascular pathology and mortality in AD. However, the chronic systemic inflammation causes cerebrovascular pathology, which likely aggravates pathology and neurological deficit in APP/PS1 and possibly AD patients.</dc:description>
<dc:description>ABSTRACT  i 

TABLE OF CONTENTS  iii 

LIST OF FIGURES  vi 

LIST OF TABLES  viii 

LIST OF ABBREVATION  ix 

I.INTRODUCTION  1  

A. Overview  1 

B. Alzheimer’s disease (AD) and inflammation  3 

C. Neuroinflammation  4 

D. Systemic inflammation and AD  5 

E. Vascular dysfunction  7 

F. Aβ degradation enzyme  8 

G. Rheumatoid arthritis (RA)  9 

H. Specific aims of the study  11 

II.MATERIALS AND METHODS  12 

A.MATERIALS  12 

1. Animals  12 

2. Reagents  12 

B. METHODS  13 

1. Induction of CIA  13 

2. Analysis of plasma IL-1β and TNF-α  13 

3. Tissue preparation  13 

4. Aβ ELISA  14 

5. Immunohistochemistry  14 

6. Image analysis of amyloid plaque burden, activated microglia/macrophages, and vascular pathology  15 

7. Extravasation of Evans blue (EB) and IgG Western blotting 16 

8. Aβ degradation enzyme ELISA  16 

9. Quantitative real-time PCR  17 

10. Morris water maze (MWM)  17 

11. Y-Maze  18 

12. Statistical analysis  19 

III. RESULTS  20 

A. Effects of CIA on presymptomatic stage of APP/PS1 mice  20 

1. Induction of collagen-induced arthritis (CIA) in APP/PS1 mice  20 

2. Effects of CIA on amyloid plaque pathology in APP/PS1 mice  25 

3. Enhanced activation of microglia/macrophages in APP/PS1 mice  28 

4. Effects of CIA on permeability of the blood-brain barrier (BBB) in APP/PS1 mice  34 

5. Effects of CIA on cerebrovascular pathology in APP/PS1 mice  37 

6. Effects of CIA on mortality in APP/PS1  40 

B. Effects of CIA on postsymptomatic stage of APP/PS1 mice  41 

1. CIA improves spatial learning and memory in APP/PS1 mice  41 

(1) Morris water maze (MWM)  41 

(2) Y-Maze  41 

2. CIA reduces amyloid plaque burden  45 

3. CIA reduces Aβ peptide levels  47 

4. CIA reduces microglial activation  48 

5. CIA increases tPA activity and decreases PAI-1 (tPA inhibitor)  51 

6. CIA reduces oxidative stress in APP/PS1 mice  54 

7. CIA enhances the permeability of the BBB and the pathology of the cerebrovessel 56 

8. CIA enhances mortality in APP/PS1  59 

IV. DISCUSSSION  64 

V. CONCLUSION  72 

REFERENCES  73 

국문요약  87</dc:description>
<dc:description>Doctor</dc:description>
<dc:date>2012-11-06T01:12:01Z</dc:date>
<dc:date>2012-11-06T01:12:01Z</dc:date>
<dc:date>2012</dc:date>
<dc:date>2012</dc:date>
<dc:type>Thesis</dc:type>
<dc:type>Theses</dc:type>
<dc:identifier>http://repository.ajou.ac.kr/handle/201003/7637</dc:identifier>
<dc:identifier>http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000012215</dc:identifier>
<dc:identifier>000000012215</dc:identifier>
<dc:language>en</dc:language>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>